Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated just now
Peer-reviewedCC BYDentistry Journal

Deciphering Nano–Bio Interactions of Hyaluronic Acid-Clove Carbon Dots for Multifunctional Endodontic Nanotherapy

  1. 1Applied Nano-Bio Therapeutics Laboratory, Department of Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, Tamil Nadu, India

Abstract

Background: Streptococcus mutans (S. mutans) plays a major role in dental biofilm-related infections and contributes to antimicrobial resistance. Therefore, the development of biocompatible nanomaterials with antibacterial, antibiofilm, and regenerative properties is important for dental applications. Methods: In this study, hyaluronic acid and clove extract were used as natural precursors to synthesize hyaluronic acid-clove carbon dots (HCCDs) through a hydrothermal method. The synthesized HCCDs were characterized by XRD, FTIR, TEM, SEM, SAED and EDAX analysis. The antibacterial and antibiofilm activities against S. mutans were tested. Cell viability tests, AO/PI staining, morphological observation and wound-healing assays were used to evaluate cytocompatibility in MG-63 cells. Results: A broad peak (23.449) observed from XRD coincided with an amorphous graphitic carbon structure. TEM images showed the presence of a spherical nanostructure with an average size of 4 ± 2 nm. The FTIR result verified the presence of hydroxyl, carbonyl and oxygen-containing functional groups on the HCCD surface. Their synthesized HCCDs exhibited noteworthy antibacterial and antibiofilm activity with an MIC of 62.5 µg/mL against the S. mutans. Low toxicity toward MG-63 cells was observed, with 86% cell viability at 200 µg/mL in the cytocompatibility study. Additional good cellular compatibility was confirmed using AO/PI staining and morphological analysis. Furthermore, normal cell migration was observed, as wound healing assays showed no significant difference in closure between the treated and control groups. Conclusion: HCCDs exhibited antibacterial, antibiofilm, biocompatible, and wound-healing properties, highlighting their potential for dental nanomedicine and the treatment of oral biofilm-associated infections.

Related

  1. Carboxymethylcellulose/Hyaluronic Acid Hybrid Nanoconjugates: Toward Multifunctional Platforms for Melanoma Skin Cancer Theranostics.
    Deborah V Miranda, Alexandra A P Mansur, Herman S Mansur +1
    Gels (Basel, Switzerland)Peer-reviewedCC BYFull textInorganic & organometallic chemistryEurope PMCDOAJ
  2. Silk Fibroin–Polyphenol Gels and Hydrogels: Molecular Interactions, Gelation Strategies, Responsive Behaviors, and Multifunctional Applications
    Simeng Ma, Zhuanghong Wang, Honghao Fan +1
    GelsPeer-reviewedCC BY7 citedMaterials & polymersOpenAlex
  3. Plaque‐Hepatic Targeting Nanotherapy Disrupts the PCSK9‐LOX‐1 Axis to Suppress oxLDL in Atherosclerosis
    Yi Duan, Yijie Qiu, Yan Zhu +5
    Advanced SciencePeer-reviewedCC BY 4.0Full textMaterials & polymersPMC
  4. A bibliometric analysis of global research trends in tumor microenvironment based nanotherapy.
    Beibei Wu, Rui Li, Yufei Yang +6
    Discover nanoPeer-reviewedCC BY-NC-NDFull textMaterials & polymersEurope PMC
  5. 3D-Printable Granular Hydrogel Composed of Hyaluronic Acid-Chitosan Hybrid Polyelectrolyte Complex Microgels
    Armin Amirsadeghi, Shahriar Mahdavi, Paula Jager +2
    BiomacromoleculesPeer-reviewedCC BY-NC-ND 4.0Full text8 citedMaterials & polymersCondensed matterHAL
BibTeX
@article{mohanprasanth2026deciphering,
  title = {{Deciphering Nano–Bio Interactions of Hyaluronic Acid-Clove Carbon Dots for Multifunctional Endodontic Nanotherapy}},
  author = {Aruchamy Mohanprasanth and Natesan Thirumalaivasan},
  journal = {Dentistry Journal},
  year = {2026},
  month = jul,
  doi = {10.3390/dj14070449},
  url = {https://doi.org/10.3390/dj14070449},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Deciphering Nano–Bio Interactions of Hyaluronic Acid-Clove Carbon Dots for Multifunctional Endodontic Nanotherapy
AU  - Aruchamy Mohanprasanth
AU  - Natesan Thirumalaivasan
PY  - 2026
DA  - 2026/07/17
JO  - Dentistry Journal
DO  - 10.3390/dj14070449
UR  - https://doi.org/10.3390/dj14070449
AB  - Background: Streptococcus mutans (S. mutans) plays a major role in dental biofilm-related infections and contributes to antimicrobial resistance. Therefore, the development of biocompatible nanomaterials with antibacterial, antibiofilm, and regenerative properties is important for dental applications. Methods: In this study, hyaluronic acid and clove extract were used as natural precursors to synthesize hyaluronic acid-clove carbon dots (HCCDs) through a hydrothermal method. The synthesized HCCDs were characterized by XRD, FTIR, TEM, SEM, SAED and EDAX analysis. The antibacterial and antibiofilm activities against S. mutans were tested. Cell viability tests, AO/PI staining, morphological observation and wound-healing assays were used to evaluate cytocompatibility in MG-63 cells. Results: A broad peak (23.449) observed from XRD coincided with an amorphous graphitic carbon structure. TEM images showed the presence of a spherical nanostructure with an average size of 4 ± 2 nm. The FTIR result verified the presence of hydroxyl, carbonyl and oxygen-containing functional groups on the HCCD surface. Their synthesized HCCDs exhibited noteworthy antibacterial and antibiofilm activity with an MIC of 62.5 µg/mL against the S. mutans. Low toxicity toward MG-63 cells was observed, with 86% cell viability at 200 µg/mL in the cytocompatibility study. Additional good cellular compatibility was confirmed using AO/PI staining and morphological analysis. Furthermore, normal cell migration was observed, as wound healing assays showed no significant difference in closure between the treated and control groups. Conclusion: HCCDs exhibited antibacterial, antibiofilm, biocompatible, and wound-healing properties, highlighting their potential for dental nanomedicine and the treatment of oral biofilm-associated infections.
SN  - 2304-6767
ER  -